Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Briboy....VTSI (.092)on watch, news just released, see below:
VTSI VirTra Systems Receives New $1 Million Order From Gander Mountain
2011-06-20 09:40 ET - News Release
TEMPE, AZ -- (MARKET WIRE) -- 06/20/11
Bob Ferris, VirTra Systems' CEO (PINKSHEETS: VTSI), today announced that VirTra has received another order from Gander Mountain, which marks the continued rollout of Gander Mountain Academies. Like the other locations before them, each Gander Mountain Academy location offers the most advanced and convenient firearms training ever made available to the public on a widespread basis.
Each standard Gander Mountain Academy includes: the world's most immersive firearms training simulator the VirTra 300? with five screens surrounding the user, the VirTra 180? simulator with three screens, multiple lanes of the VirTra Range? simulator, which is the world's most realistic simulated shooting range with a large variety of targets and courses of fire, as well as various recoil kits and accessories to support all of the simulators.
Bob Ferris, CEO of VirTra Systems, said, "VirTra is very pleased to receive this next order from Gander Mountain. This project is revolutionizing firearms training for the public one location at a time, while adding an educational and exciting new dimension to the Gander Mountain retail experience."
06/06/2011 7:04:00 AM - News Release
ALBUQUERQUE, N.M. -- (Business Wire)
In a move to accelerate applications of a novel cancer detection and treatment technology, Manhattan Scientifics (OTCBB: MHTX) today announced that it has acquired all of Senior Scientific, LLC and its affiliate Scientific Nanomedicine Inc. Primarily developed by Edward R. Flynn, Ph.D, the groundbreaking nanotechnology can detect and measure initial cancers and cancer metastases much earlier than is possible with current techniques. The technology is applicable to breast, prostate, ovarian, pancreatic, brain, and other cancers years earlier than current diagnostic techniques. Terms of the acquisition will be filed in a Form 8K with the SEC.
The technology uses magnetic nanoparticles combined with antibodies that target specific kinds of cancer cells. Special instrumentation can precisely locate and accurately count the number of cancer cells present based on the nanoparticles bound by antibodies to the cancer cells. The nanoparticles are nontoxic, and the instrumentation does not require radiation or strong magnetic fields. The new technology can detect, locate, and measure tumors that are only 1/1000 the size required by conventional imaging techniques. As an example, the new technology can detect breast cancer several years earlier than is possible with a mammogram.
The system can be used for both diagnostics and targeted therapies. Manhattan Scientifics has applied for 24 patents to protect the inventions and three leading research hospital cancer centers in the U.S have expressed interest in collaborations with this technology.
Manhattan CEO Manny Tsoupanarias said, “It gives me great pleasure to announce this acquisition and to welcome Dr. Flynn and his team to the Manhattan Scientifics’ family. Dr. Flynn has transitioned from his earlier role as a key Los Alamos Laboratory nuclear physicist applying his knowledge of physics and avoiding the use of the scalpel in his approach to dealing with cancer. He and his colleagues at Senior Scientific and at the University of New Mexico Health Science Center have developed a novel, out-of-the-box approach to early detection and treatment of cancer. The technology is in keeping with our company’s focus on commercializing nanotechnologies in the field of advanced medicine.
“Three years ago we acquired Metallicum Inc. another nano technology for advanced medicine, which propelled our company to a cash-flow-positive state. Together with our Fortune/1000 industrial partner (NYSE: CRS) we remain extremely optimistic about future prospects for our Metallicum unit. Now, with the acquisition of Senior Scientific, LLC, we anticipate repeating our history and expanding our overall business,” Tsoupanarias said.
Marvin Maslow, Founder & Chairman Emeritus of Manhattan Scientifics, said, “The Senior Scientific technology is stunning and the enthusiastic acceptance of it for experimental clinical work by America's most important cancer hospitals and cancer research centers is equally stunning. Our team leaders, V. Gerald Grafe and Spencer Falk, in collaboration with Dr. Richard Larson of the University of New Mexico, have shown great determination to accelerate the commercialization process.”
Edward R. Flynn, PhD, founder of Senior Scientific and Chief Scientist said, “I will continue to play a major role in developing this technology towards experimental and clinical applications. The past grants I received from the National Institutes of Health helped take the technology from concept to a working prototype. Now with the major commercializing role of Manhattan Scientifics, we can rapidly advance the technology from the laboratory to a clinical environment working cooperatively with the major cancer research centers in the U.S. This is truly an exciting time.”
THRA-->.03's hitting -- GOOD VOLUME today!
Mr. Wowza EXPLOSIVE? I like explosive plays, even silent ones like THRA .04 +5% super low float with solid news out this am!
Have a great weekend!
THRA .038 x .04 very low floater, good for a few points. News out on Silver play in B.C.
THRA .038 x .039 up on low volume!
Morning Dave....don't go yet, check out THRA some solid news out from this Silver mining company!
VITA >>>> Holzer Holzer & Fistel, LLC Announces Investigation into the Proposed Buyout of Orthovita, Inc.
2011-05-16 10:42 ET - News Release
ATLANTA -- (Business Wire)
Holzer Holzer & Fistel, LLC is investigating whether the directors of Orthovita, Inc. (“Orthovita”) (NASDAQ: VITA) complied with their fiduciary duties in approving the proposed acquisition of the company by Stryker Corporation. According to Orthovita’s announcement, Stryker will commence a tender offer to purchase all outstanding shares of VITA for $3.85 per share. The investigation seeks to determine, among other things, whether the consideration to be paid to Orthovita shareholders is fair and adequate.
Current holders of Orthovita common stock with questions concerning their legal rights are encouraged to contact Holzer Holzer & Fistel, LLC and its attorneys Michael I. Fistel, Jr., Esq., or Marshall P. Dees, Esq. via email at mfistel@holzerlaw.com, or mdees@holzerlaw.com, or via toll-free telephone at (888) 508-6832.
THRA could spike north on little volume imo!
Still holding Probe, i have enough at these levels...u still in it?
If you traded that one right, you should be spending your earnings down in the Islands lol!
I'm still very optimistic that MHTX will double from here.
Anyone: Comments as to this mornings trading?
good morning Suetta, BYOC .032 +33 points on mornings news!
PHAR....check out todays news!
Morning, 1 left on ELTP at .089 Bids stacking!
Hey VZ3.... what's happening?
ELTP....read the news!
ELTP >>> Elite Pharmaceuticals Announces First Shipment of Generic Phentermine HCl Tablets
2011-04-07 08:00 ET - News Release
NORTHVALE, N.J., April 7, 2011 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today that the initial shipment of phentermine HCl 37.5 mg tablets, the generic version of Adipex-P® 37.5 mg tablets, was made, triggering a milestone payment under the License, Manufacturing and Supply Agreement with Precision Dose and its wholly owned subsidiary TAGI Pharma, Inc. TAGI Pharma will distribute the product as part of a multi-product distribution agreement.
Phentermine HCl is a member of the amphetamine and phenethylamine class. It is an appetite suppressant used to help reduce weight in obese patients when used short-term and combined with exercise, diet, and behavioral modification.
For the most recent twelve months ending December 2010, Adipex-P® and its generics had total U.S. sales of approximately $40 million according to IMS Health Data.
Good to see that news....lets see her get back up in pps!
Probe Mines increases private placement to $25-million
2011-04-04 10:02 ET - News Release
Mr. David Palmer reports
PROBE MINES ANNOUNCES PRICING AND UPSIZES BROKERED PRIVATE PLACEMENT TO C$25 MILLION
Probe Mines Ltd. has priced and upsized its previously announced best-efforts marketed private placement. Probe will sell 18.52 million units at a price of $1.35 for gross proceeds of $25,002,000. Each unit will consist of one common share and one-half of one common-share purchase warrant. BMO Capital Markets acted as sole agent for the offering. The offering is expected to close on or about April 21, 2011.
Each whole common-share purchase warrant will entitle the holder to purchase one additional common share of the company at a price of $1.70 for a period of two years following the closing of the offering. If the volume-weighted average share price of the common shares on the TSX Venture Exchange is greater than $2.70 per common share for a period of 20 consecutive trading days at any time following the issuance of the warrants, the company may accelerate the expiry date of the warrants by issuing a press release announcing the reduced warrant term, whereupon the warrants will expire on the 30th calendar day after the date of the press release.
The company intends to use the net proceeds from the offering to finance the exploration and development of the Borden Lake property as well as other projects, and for general corporate purposes.
The offering is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including the approval of the TSX Venture Exchange and applicable securities regulatory authorities.
Probe halted.... hopefully for good news!
FOGC running with a full tank of Premium Gasoline!!!
Oil & Gas play: Titan Oil & Gas (OTCBB: TNGS) Acquires Interest in Five Producing Oil Wells
2011-03-29 09:30 ET - News Release
LAS VEGAS, NV -- (MARKET WIRE) -- 03/29/11
Titan Oil & Gas, Inc. (OTCBB: TNGS) ("Titan" or "the Company") is pleased to announce it has acquired an interest in five producing oil wells operated by Petrobakken Energy, a multi-billion dollar oil company based out of Calgary, Alberta.
The wells are located on 800 acres of land approximately 80 miles northwest of Edmonton in the Leaman area. Current gross production is approximately 60 barrels of oil a day and there is potential for another well to be drilled in the future.
"We are very pleased to have achieved our goal of becoming a producing oil company," said Jarnail Dhaddey, President of Titan. "We are also very pleased to be associating with industry leaders and look forward to using these relationships to build Titan's producing resource base and to enhance shareholder value in the coming months."
Titan Oil & Gas, Inc. (OTCBB: TNGS) is a producing US-based company aggressively exploring and acquiring land in key petroleum-producing regions of Alberta. Its projects are located in areas of excellent infrastructure and high drilling activity, and the company plans on using the most current and proven cost effective technologies to generate long-term reserves and production while maximizing shareholder value. For more information on Titan Oil & Gas, please visit http://www.titanoilinc.com.
Disclaimer
Titan Oil & Gas is a trademark of Titan Oil & Gas Inc. This announcement contains forward-looking statements which involve risks and uncertainties that include, among others, limited operating history, risks related to petroleum exploration, limited access to operating capital, and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. More information is included in Titan's filings with the Securities and Exchange Commission which may be accessed through the SEC's web site at http://www.sec.gov.
Contact
Investor Relations
702-562-4315
info@titanoilinc.com
www.titanoilinc.com
MHTX .0845 you may want to have a look at todays news!
Keep an eye on MHTX, news just released!
News out>>> Manhattan Scientifics & Senior Scientific Cancer Project Enters Clinical Trial
2011-03-21 09:22 ET - News Release
The Technology was Described in “THE GRAY SHEET” Publication
“The Gray Sheet” Provides In-Depth Specialized Coverage of the Medical Device, Diagnostic & Instrumentation Industries
Article Notes Active Partnering Discussions with Large Drug, Device and Imaging Companies
Manhattan Scientifics, Inc. (OTCBB: MHTX) said today that “The Gray Sheet" has written about an initial clinical trial that has enrolled its first 35 patients to measure leukemia cells using a unique nanotechnology-based magnetic imaging method developed by Senior Scientific LLC, which has licensed the technology to Manhattan Scientifics, Inc.
An authorized copy of the article authored by Zach Miners follows:
Nanotechnology Cancer Detection Technology Moves To Clinical Trial
A first-in-man clinical trial to measure very small levels of residual leukemia cells using a unique nanotechnology-based magnetic imaging method has enrolled its first 35 patients.
The technology, in development by Senior Scientific and nanomedicine-focused investment firm Manhattan Scientifics, is still years from reaching the market, but the firms say they are in active partnering discussions with several large drug, device and imaging companies.
The trial, which will enroll 60 patients in all, is expected to be completed within two years. In leukemia, the focus is on monitoring the effect of chemotherapy by detecting residual disease. The technique also has applications in gauging therapy response in a range of other cancers, according to the developers.
“If you’re doing chemotherapy, hyperthermia or even surgery, we can use our device to see that you get it all,” said Edward Flynn, founder and president of Senior Scientific. “The leukemia case is just one example.”
The companies are also assessing the tool for early detection of breast cancer, other malignancies and Alzheimer's disease, he said.
Magnetically Measuring Cancer Cells
The technique being studied in the leukemia trial involves first extracting bone marrow cells from leukemia patients; injecting the cell sample with magnetic nanoparticles linked to antigens that preferentially bind to leukemia cells rather than normal cells; and measuring the concentration of leukemia cells in the sample by employing a patented magnetic biopsy needle and a specialized sensor array for magnetic fields.
Flynn says the technology can detect "minimal residual disease" down to 0.3% of a sample. Achieving that level of sensitivity is the primary endpoint of the study, which is being conducted at the University of New Mexico’s Health Sciences Center. Comparatively, current biopsy techniques typically fail to detect leukemia cells that account for less than 5% of a sample, he notes.
Detecting the presence of minimal residual disease provides information on how well chemotherapy is working, and when it might be appropriate to stop treatment or change doses or drugs. More refined monitoring of chemotherapy is particularly important in pediatric leukemia, Flynn says, because the treatments can have significant short- and long-term adverse effects on the young patients.
Flynn also specifically pressed the promise of the technology for early detection of breast cancer, noting that magnetic nanoparticle- based detection can localize a breast tumor containing 100,000 cells – or 1/1000th of what a mammogram requires.
The magnetic-based detection also limits the potential for false positives and is not affected by the presence of scar tissue from surgeries and implants, he points out.
In Vivo Approach Is Next Step
Ultimately, Flynn says the goal is to perform the technique by an in vivo approach, where the antigen-linked nanoparticles are injected into the body, providing a means to detect the precise location of cancer cells.
This presents a potential strategy for monitoring tumor evolution. As the tumor grows or shrinks, for instance, the number of nanoparticles bound to the cancer cells also grows or shrinks and could be promptly measured, Flynn suggests.
It also could allow for more targeted chemotherapy, limiting adverse effects of widespread treatment.
“It’s a smart-bombing approach,” explains Marvin Maslow, founder and chairman emeritus at Manhattan Scientifics.
In February 2010, Manhattan acquired rights to all commercial applications of the technology, which was developed by Flynn.
Flynn, a nuclear physicist by training, founded privately held Senior Scientific in 1996 to develop magnetic-based cancer cell detection. The firm has received $7 million in research grants from the National Institutes of Health since 2002, mostly through the Small Business Innovation Research program.
PGIE starting to move north!!!
Any thoughts on SSU.V?
NOT.V significant news just released:
Noront's Eagle's Nest at 11 Mt of 1.78% Ni M+I
2011-03-04 08:51 ET - News Release
Mr. Wesley Hanson reports
NORONT ANNOUNCES SIGNIFICANT RESOURCE INCREASE AT EAGLE'S NEST
Noront Resources Ltd. is providing an updated mineral resource estimate for the Eagle's Nest deposit, located at its McFaulds Lake property in the James Bay Lowlands.
The NI 43-101 Resource estimate for Eagle's Nest deposit has significantly increased and is now estimated to contain:
Main Zone
Measured and indicated resource of 11.0million tonnes grading 1.78% Ni, 0.98% Cu, 0.99 gpt Pt and 3.41 gpt Pd and 0.20 gpt Au;
Inferred resource of 9.0 million tonnes grading 1.10% Ni, 1.14% Cu, 1.16 gpt Pt and 3.49 gpt Pd and 0.30 gpt Au;
East Zone
Inferred resource of 1.6 million tonnes grading 0.31% Ni, 0.09% Cu, 0.12 gpt Pt and 0.45gpt Pd and 0.04 gpt Au;
Noront's President and CEO, Wes Hanson, states: "For a second consecutive year the Company has realized a resource increase at Eagle's Nest. Drilling at Eagle's Nest in 2010 was undertaken to improve the geological confidence of the mineral resource disclosed in March 2010 and to increase the inferred resource at depth. This updated resource estimate confirms that both objectives were successfully accomplished. The East Zone, approximately 200 metres east of Eagle's Nest, is indicative of the potential for future resource increases within the Eagle's Nest Complex. Our winter exploration continues as planned with two drills currently operating. One drill is testing targets at AT12, the second drill is testing targets at the Western Intrusive Complex. We are also expanding the ground based geophysical survey to assist in prioritizing previously identified airborne targets within the Eagle's Nest Complex."
The updated mineral resource is based on the exploration drilling completed during the 2010 field season, and updates the previous NI 43-101 compliant resource estimate for the Eagle's Nest Deposit announced on March 9, 2010.
During 2010, the Company drilled 20,200 metres at Eagle's Nest. The drilling was focused on improving the confidence and classification of previous resources estimates through in-fill drilling. In addition, the 2010 program also aimed at expanding the deposit at depth based on a drilling program. Despite challenges in the deep drilling program, the Company was successful in both objectives.
The extent of the mineralization now extends to a depth of approximately 1,650 metres from surface. The Eagle's Nest resource includes inferred resource along strike and down dip below 1,100 metres providing significant potential for further resource growth. It is anticipated that the nickel grade of the inferred resource will increase during further delineation drilling. Due to the depth of this inferred resource, further drilling on this target will be more effective from an advanced exploration program utilizing an underground exploration ramp.
Morning Carnac...you may also want to check out Noront (NOT.V) this should be good for some $$$$ below is half the news release:
Noront's Eagle's Nest at 11 Mt of 1.78% Ni M+I
2011-03-04 08:51 ET - News Release
Mr. Wesley Hanson reports
NORONT ANNOUNCES SIGNIFICANT RESOURCE INCREASE AT EAGLE'S NEST
Noront Resources Ltd. is providing an updated mineral resource estimate for the Eagle's Nest deposit, located at its McFaulds Lake property in the James Bay Lowlands.
The NI 43-101 Resource estimate for Eagle's Nest deposit has significantly increased and is now estimated to contain:
Main Zone
Measured and indicated resource of 11.0million tonnes grading 1.78% Ni, 0.98% Cu, 0.99 gpt Pt and 3.41 gpt Pd and 0.20 gpt Au;
Inferred resource of 9.0 million tonnes grading 1.10% Ni, 1.14% Cu, 1.16 gpt Pt and 3.49 gpt Pd and 0.30 gpt Au;
East Zone
Inferred resource of 1.6 million tonnes grading 0.31% Ni, 0.09% Cu, 0.12 gpt Pt and 0.45gpt Pd and 0.04 gpt Au;
Noront's President and CEO, Wes Hanson, states: "For a second consecutive year the Company has realized a resource increase at Eagle's Nest. Drilling at Eagle's Nest in 2010 was undertaken to improve the geological confidence of the mineral resource disclosed in March 2010 and to increase the inferred resource at depth. This updated resource estimate confirms that both objectives were successfully accomplished. The East Zone, approximately 200 metres east of Eagle's Nest, is indicative of the potential for future resource increases within the Eagle's Nest Complex. Our winter exploration continues as planned with two drills currently operating. One drill is testing targets at AT12, the second drill is testing targets at the Western Intrusive Complex. We are also expanding the ground based geophysical survey to assist in prioritizing previously identified airborne targets within the Eagle's Nest Complex."
The updated mineral resource is based on the exploration drilling completed during the 2010 field season, and updates the previous NI 43-101 compliant resource estimate for the Eagle's Nest Deposit announced on March 9, 2010.
During 2010, the Company drilled 20,200 metres at Eagle's Nest. The drilling was focused on improving the confidence and classification of previous resources estimates through in-fill drilling. In addition, the 2010 program also aimed at expanding the deposit at depth based on a drilling program. Despite challenges in the deep drilling program, the Company was successful in both objectives.
The extent of the mineralization now extends to a depth of approximately 1,650 metres from surface. The Eagle's Nest resource includes inferred resource along strike and down dip below 1,100 metres providing significant potential for further resource growth. It is anticipated that the nickel grade of the inferred resource will increase during further delineation drilling. Due to the depth of this inferred resource, further drilling on this target will be more effective from an advanced exploration program utilizing an underground exploration ramp.
ORRV on the move:
Oceanic Research and Recovery Enters Into Joint Venture With Deep Marine Salvage
2011-03-03 10:01 ET - News Release
PEORIA, Ill., March 3, 2011 /PRNewswire/ -- Oceanic Research and Recovery Inc. (Pink Sheets: ORRV), a marine salvage and exploration company, today announced that it has entered into a joint venture agreement with Deep Marine Salvage ("DMS").
DMS is comprised of an international team of experienced deep water marine contractors bought together to form Deep Marine Salvage. The entire staff at DMS has been selected because of their previous involvement and extensive experience in salvage and deep water operations around the world.
ORRV and DMS will work together to locate and recover cargo from shipwrecks internationally located in deep water. Under the terms of the agreement, any cargo recovered will be divided between the companies on a 50\50 basis.
"We're very pleased to be working with the DMS team!" said Scott Heimdal, CEO of ORRV. "Partnering with DMS greatly accelerates our entry into the arena of deep ocean salvage and puts our business plan well ahead of schedule."
PRB.V news ($1.77 +8%) 03/03/2011 5:18:00 AM - News Release
Mr. David Palmer reports
PROBE MINES ACQUIRES ADDITIONAL PROPERTY ON ITS BORDEN LAKE PROJECT NEAR CHAPLEAU, ONTARIO AND PROVIDES DRILLING UPDATE
Probe Mines Ltd. has entered into an option agreement to acquire a 100-per-cent interest in the mineral rights of one patented mining claim adjacent to its Borden Lake project near Chapleau, Ont. Probe has the right to earn a 100% interest in the mineral rights of the property by making cumulative cash payments totaling $20,000 and issuing 45,000 shares to the vendors over the three-year period of the option agreement. The vendors will also maintain a 1% net smelter royalty, of which 0.5% can be purchased back by Probe for $500,000. The transaction is subject to regulatory approval.
A total of 27 holes have now been completed on the project representing approximately 960m of strike length along the gold-bearing horizon. In this second-phase program, holes BL10-09 to BL11-26 targeted the northwest (NW) continuation of the mineralized zone from discovery hole BL10-02. Drill sections were spaced 100 metres apart with two holes per section testing the horizon at approximately 150 metres and 200 metres depth. Three deeper holes, drilled on sections 0, 200 and 500 metres NW have also been completed and target mineralization at the 300 metre vertical depth level. The mineralized horizon has now been tested up to 700m NW of the discovery section and remains open in all directions. Further drilling will begin testing the southeast strike extent of the mineralization, beginning with hole BL11-27, 100 metres to the southeast of the discovery section.
Sampling has been completed for holes BL11-16 to BL11-25 and results are expected shortly. They will be released as soon as they are received.
Updated maps of Probe's land-holdings and drilling plans are available on the Company's website at www.probemines.com.
Dr. David Palmer, President of Probe, comments, "Our focus has been on acquiring key properties and this acquisition will now allow us to concentrate more energy on the exploration of our holdings at Borden Lake. We are very encouraged by the results coming from the Borden Lake project and, though still early in the program, these results indicate the potential for a significant volume of mineralization. Our goal now is to determine the scale of the mineralization and quantify it through continued drilling. We hope to complete our first-pass drilling on the southeastern section sometime during early to mid-Spring and anticipate commencing a 43-101-compliant resource estimate calculation immediately after. The expanded property also has a number of untested geophysical targets which resemble the discovery zone, and these will also become the focus of exploration in the near future."
We seek Safe Harbor.
Morning Carnac, Probe news out early this morning:
03/03/2011 5:18:00 AM - News Release
Mr. David Palmer reports
PROBE MINES ACQUIRES ADDITIONAL PROPERTY ON ITS BORDEN LAKE PROJECT NEAR CHAPLEAU, ONTARIO AND PROVIDES DRILLING UPDATE
Probe Mines Ltd. has entered into an option agreement to acquire a 100-per-cent interest in the mineral rights of one patented mining claim adjacent to its Borden Lake project near Chapleau, Ont. Probe has the right to earn a 100% interest in the mineral rights of the property by making cumulative cash payments totaling $20,000 and issuing 45,000 shares to the vendors over the three-year period of the option agreement. The vendors will also maintain a 1% net smelter royalty, of which 0.5% can be purchased back by Probe for $500,000. The transaction is subject to regulatory approval.
A total of 27 holes have now been completed on the project representing approximately 960m of strike length along the gold-bearing horizon. In this second-phase program, holes BL10-09 to BL11-26 targeted the northwest (NW) continuation of the mineralized zone from discovery hole BL10-02. Drill sections were spaced 100 metres apart with two holes per section testing the horizon at approximately 150 metres and 200 metres depth. Three deeper holes, drilled on sections 0, 200 and 500 metres NW have also been completed and target mineralization at the 300 metre vertical depth level. The mineralized horizon has now been tested up to 700m NW of the discovery section and remains open in all directions. Further drilling will begin testing the southeast strike extent of the mineralization, beginning with hole BL11-27, 100 metres to the southeast of the discovery section.
Sampling has been completed for holes BL11-16 to BL11-25 and results are expected shortly. They will be released as soon as they are received.
Updated maps of Probe's land-holdings and drilling plans are available on the Company's website at www.probemines.com.
Dr. David Palmer, President of Probe, comments, "Our focus has been on acquiring key properties and this acquisition will now allow us to concentrate more energy on the exploration of our holdings at Borden Lake. We are very encouraged by the results coming from the Borden Lake project and, though still early in the program, these results indicate the potential for a significant volume of mineralization. Our goal now is to determine the scale of the mineralization and quantify it through continued drilling. We hope to complete our first-pass drilling on the southeastern section sometime during early to mid-Spring and anticipate commencing a 43-101-compliant resource estimate calculation immediately after. The expanded property also has a number of untested geophysical targets which resemble the discovery zone, and these will also become the focus of exploration in the near future."
We seek Safe Harbor.
Good eye buddy, like i said... patience here and we can all make a half decent buck!
We have a winner, thanks for posting the link.
MXXH news: Matrixx Resource Holdings Finalizes Acquisition of Sanger Heirs, Live Oak County, Texas Prospect
2011-02-15 11:31 ET - News Release
HOUSTON, TX -- (MARKET WIRE) -- 02/15/11
Matrixx Resource Holdings, Inc. (PINKSHEETS: MXXH) is pleased to announce that it has finalized and closed on the transaction to acquire a 25% interest in the 82.2 acre lease known as the Sanger Heirs Prospect in Live Oak County, Texas.
As previously announced, Tejones intends to test the upper Wilcox series of sands and log at 7,850 feet. Drilling to test depth will be expected to take approximately 15 days. Through a farm-out agreement made by investors on the prospect, there have been discussions and recommendations of two additional wells to be drilled shortly after the Sanger Heirs #1.
Plans with the operator are to begin preparing the site as soon as practicable, with transporting the rig on site immediately thereafter. Additional updates will be made as they become available. Additional information on this transaction will be filed on form 8K, Item 2.01 under Completion of Acquisition of Assets.
Safe Harbor Statement: This press release contains forward-looking statements as defined in The Private Securities Litigation Reform Act of 1995 (the "Act"). In particular, when used in the preceding discussion, the words "plan," "confident that," "believe," "scheduled," "expect," or "intend to," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties, and actual results may differ materially from those expressed in any forward-looking statement. Such risks and uncertainties include, but are not limited to, the ability of Matrixx to complete the proposed acquisition(s), the results of Matrixx's due diligence review of the candidate(s), the success of the business of the acquisition candidate(s), including the ability of Matrixx to continue to sell the applicable products and the acceptance of those newly designed products by the market, market conditions, the general acceptance of the Company's products and technologies, competitive factors, timing, and other risks described in the Company's SEC reports and filings.
Media & Investor Relations:
Alex Livak
Tel: 917-239-6800
Email: info@mxxh.net
http://www.mxxh.net
PPTO .093 +32 points on mornings news:
Precision Petroleum Corporation: Quinlan Rework Program Estimated to Increase Monthly Revenue by $10,000.00 Per Month
Morning, CBAI MMTE getting fired up!
You still following that one?